Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
JOP ; 4(5): 184-6, 2003 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-14526130

RESUMEN

CONTEXT: Acute pancreatitis has been reported in a few cases treated with macrolides or glucocorticoids. CASE REPORT: We report the case of a 58 year old patient who, after 2 days of treatment with roxithromycin and betamethasone, manifested acute pancreatitis. Other causes of the disease were ruled out. No re-occurrence of pancreatitis was observed in a 16 month follow-up. CONCLUSION: Our case sheds new light on glucocorticoid pancreatotoxicity and confirms the role of macrolides as potential pancreatotoxic drugs.


Asunto(s)
Betametasona/efectos adversos , Pancreatitis/inducido químicamente , Roxitromicina/efectos adversos , Enfermedad Aguda , Betametasona/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Infecciones del Sistema Respiratorio/complicaciones , Infecciones del Sistema Respiratorio/tratamiento farmacológico , Roxitromicina/uso terapéutico
2.
Biorheology ; 40(1-3): 411-5, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-12454434

RESUMEN

The promising concept of cell transplantation and cardiac tissue engineering has been developed in the last few years and focused on strategies attempting to replace dysfunctional, necrotic, and/or apoptotic cardiomyocytes with new cells of mesodermal origin. Transplantation of autologous cells minimizes the risk of neoplasia and avoids immune rejection associated with allogenic or xenogenic cells and recent data hold enormous hopes for short term clinical practices. Tissue engineering represents another promising approach that makes possible the creation of new functional tissues to replace the lost or failing one. Three-dimensional polymeric scaffolds provide the mechanical support for the candidate cells until the formation of cardiac-like tissue prior to surgical repair of the infarcted myocardium. For ultimate clinical applications, further investigations have to select the appropriate cell types, to determine the sufficient number of grafted cells and to provide the long term evaluation of these strategies in the global improvements of cardiac function (neoangiogenesis, synchronous contraction and extracellular matrix remodelling).


Asunto(s)
Trasplante de Células/métodos , Insuficiencia Cardíaca/terapia , Ingeniería de Tejidos/métodos , Materiales Biocompatibles , Humanos , Músculos/citología , Músculos/trasplante , Prótesis e Implantes
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA